Skip to main content
. 2024 Feb 14;15:1343093. doi: 10.3389/fneur.2024.1343093

Table 1.

Demographic and clinical characteristics of patients.

Characteristics Stimulation group (n = 11) Sham group (n = 11) Total (n = 22)
Sex female, (%) 85.7 88.9 87.5
Age in y, mean (SD) 63.09 ± 13.69 63.09 ± 8.71 63.09 ± 2.3
Duration of illness in years, mean (SD) 5.95 ± 7.29 6.20 ± 5.63 6.07 ± 1.35
Medication, (%) Pregabalin 9.1 0 4.5
NSAR for facial pain 0 18.2 9.1
Antidepressant medication 18.2 0 9.1
Oral and maxillofacial disorders, (%) None 81.8 72.7 68.2
HO dental surgery 9.1 27.3 18.2
Craniomandibular dysfunction 9.1 0 4.5
Neurological disorder (%) None 63.6 72.7 68.2
Episodic migraine 27.3 9.1 18.2
Tinnitus 9.1 9.1 9.1
HO stroke 0 9.1 4.5
Diagnosed psychiatric disorders, (%) None 81.8 90.9 86.4
Depression 18.2 0 9.1
Somatic symptom disorder 0 9.1 4.5
Metabolic disorders, (%) Morbus Fabry 9.1 0 4.5
Hypothyroidism 0 9.1 4.5
Rheumatic diseases, (%) Rheumatoid arthritis 0 9.1 4.5
CREST-syndrome 9.1 0 4.5
Cardiovascular diseases, (%) Arterial hypertension 36.4 63.6 50
Musculoskeletal disorders, (%) Spinal stenosis 9.1 18.2 13.6
Herniated disc 9.1 9.1 9.1
Leg length discrepancy 9.1 0 4.5
Osteoarthritis 9.1 0 4.5
Gastrointestinal disorders, (%) HO gastritis 0 27.3 13.6
Gastroesophageal reflux 18.2 0 9.1
Gynecological Comorbidities, (%) HO carcinoma 0 18.2 9.1
HO hysterectomy 18.2 0 9.1
Chemotherapy, (%) HO chemotherapy 0 9.1 4.5

HO, “history of”.